Humanisierte Antikörper gegen Amyloid beta

European patent · EP2468770 · In force

Register entry

Publication number
EP2468770
Application number
EP11192705
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jul 13, 2007
Published
Jun 27, 2012
Granted
Dec 20, 2017
Protection ends at the latest
Jul 12, 2027
Next annual fee due
Jul 31, 2026
IPC classes
C07K 16/18 (2006.01)
A61P 25/28 (2006.01)
Priority
US 94328907 P 11.06.2007
US 94349907 P 12.06.2007
EP 06014730 14.07.2006
EP 06020765 02.10.2006
Divided from
EP07840408
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 1, 2025

    Change

    Published in Swissreg on 01.08.2025

  2. Aug 1, 2024

    Change

    Published in Swissreg on 01.08.2024

  3. Aug 1, 2023

    Change

    Published in Swissreg on 01.08.2023

  4. Aug 1, 2022

    Change

    Published in Swissreg on 01.08.2022

  5. Dec 20, 2017

    Granted

    Published in Swissreg on 20.12.2017

Parties

Holder

AC Immune SA

AC Immune S.A.

EPFL Innovation Park Building B, 1015 Lausanne

GENENTECH, INC.

Genentech, Inc.

One DNA Way, South San Francisco, CA 94080-4990, US

Inventor

Pfeifer, Andrea

1806 St.-Légier

Pihlgren Bosch, Maria

1052 Mont-sur-Lausanne

Muhs, Andreas

1053 Cugny

Watts, Ryan

San Mateo, CA 94402, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.